Author: Pascual-Iglesias, Alejandro; Canton, Javier; Ortega-Prieto, Ana Maria; Jimenez-Guardeño, Jose M.; Regla-Nava, Jose Angel
Title: An Overview of Vaccines against SARS-CoV-2 in the COVID-19 Pandemic Era Cord-id: o61sgfcm Document date: 2021_8_14
ID: o61sgfcm
Snippet: The emergence of SARS-CoV-2 in late 2019 led to the COVID-19 pandemic all over the world. When the virus was first isolated and its genome was sequenced in the early months of 2020, the efforts to develop a vaccine began. Based on prior well-known knowledge about coronavirus, the SARS-CoV-2 spike (S) protein was selected as the main target. Currently, more than one hundred vaccines are being investigated and several of them are already authorized by medical agencies. This review summarizes and c
Document: The emergence of SARS-CoV-2 in late 2019 led to the COVID-19 pandemic all over the world. When the virus was first isolated and its genome was sequenced in the early months of 2020, the efforts to develop a vaccine began. Based on prior well-known knowledge about coronavirus, the SARS-CoV-2 spike (S) protein was selected as the main target. Currently, more than one hundred vaccines are being investigated and several of them are already authorized by medical agencies. This review summarizes and compares the current knowledge about main approaches for vaccine development, focusing on those authorized and specifically their immunogenicity, efficacy preventing severe disease, adverse side effects, protection, and ability to cope with emergent SARS-CoV-2 variants.
Search related documents:
Co phrase search for related documents- actual rate and acute phase: 1
- acute phase and ade antibody dependent enhancement: 1
Co phrase search for related documents, hyperlinks ordered by date